參考文獻

董寧，姚詠明，曹玉玨，等，2007．嚴重燒傷患者人白細胞抗原DR定量表達的臨床意義［J］ ．中華外科雜志，45：766—769.

膿毒癥免疫調(diào)理治療臨床研究協(xié)作組，2007．烏司他丁、α1胸腺肽聯(lián)合治療嚴重膿毒癥——一種新的免疫調(diào)理治療方法的臨床研究［J］ ．中華醫(yī)學雜志，87：451—457.

盛志勇，姚詠明，2011．加強對膿毒癥免疫功能障礙及其監(jiān)測的研究［J］ ．解放軍醫(yī)學雜志，36：8—10.

盛志勇，姚詠明，林洪遠，等，2002．全身炎癥反應(yīng)和多器官功能障礙綜合征認識的變遷及形狀［J］ ．解放軍醫(yī)學雜志，27：98—100.

王正國，2003．膿毒癥研究概況［J］ ．中華創(chuàng)傷雜志，19：5—8.

姚詠明，2012．重視膿毒癥免疫功能的負向調(diào)控作用［J］ ．中華急診醫(yī)學雜志，21：117—119.

姚詠明，柴家科，盛志勇，等，2003．燒傷膿毒癥的診斷標準與防治［J］ ．中華燒傷雜志，19：65—66.

姚詠明，黃立鋒，2011．燒傷后膿毒性腦病發(fā)生機制與診治對策［J］ ．中華損傷與修復雜志，6：167—173.

姚詠明，黃立鋒，2011．調(diào)節(jié)性T淋巴細胞與嚴重燒傷膿毒癥［J］ ．中華燒傷雜志，27：81—83.

姚詠明，盛志勇，2003．我國創(chuàng)傷膿毒癥基礎(chǔ)研究新進展［J］ ．中華創(chuàng)傷雜志，19：9—12.

姚詠明，盛志勇，2004．金黃色葡萄球菌外毒素與膿毒癥及多器官損害［J］ ．中華創(chuàng)傷雜志，20：711—714.

姚詠明，盛志勇，柴家科，等，2008．燒傷膿毒癥發(fā)病機制與防治對策［J］ ．中華燒傷雜志，24：337—339.

姚詠明，盛志勇，林洪遠，等，2004．膿毒癥定義及診斷的新認識［J］ ．中國危重病急救醫(yī)學，16：321—324.

張慶紅，姚詠明，2010．關(guān)注神經(jīng)內(nèi)分泌紊亂與膿毒癥的關(guān)系及其防治策略［J］ ．中華燒傷雜志， 26：87—89.

張慶紅，姚詠明，2011．淺析膿毒癥高血糖治療的利與弊［J］ ．中華急診醫(yī)學雜志， 20：789—791.

ANGUS D C, VAN DER POLL T, 2013. Severe sepsis and septic shock ［J］. N Engl J Med, 369：840—851.

ANNANE D, BELLISSANT E, BOLLAERT P E, et al, 2009. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review ［J］. JAMA, 301: 2362—2375.

BERCZI I, QUINTANAR-STEPHANO A, KOVACS K, et al, 2009. Neuroimmune regulation in immunocompetence, acute illness, and healing ［J］. Ann N Y Acad Sci, 1153: 220—239.

CHENG B L, XIE G H, YAO S L, et al, 2007. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China ［J］. Crit Care Med, 35: 2538—2546.

DELLINGER P R, LEVY M M, RHODES A, et al, 2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2012［J］. Crit Care Med, 41: 580—637.

HATTORI Y, TAKANO K, TERAMAE H, et al, 2010. Insights into sepsis therapeutic design based on the apoptotic death pathway ［J］. J Pharmacol Sci, 114: 354—365.

HOTCHKISS R S, OPAL S, 2010. Immunotherapy for sepsis: a new approach against an ancient foe ［J］. N Engl J Med, 363: 87—89.

HUANG L F, YAO Y M, DONG N, et al, 2010. Association between regulatory T cell activity and sepsis and outcome of severely burned patients:a prospective, observational study ［J］. Crit Care, 14: R3.

HUTTUNEN R, AITTONIEMI J, 2011. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis ［J］. J Infect, 63:407—419.

JIANG L N, YAO Y M, SHENG Z Y, et al, 2012. The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication ［J］. J Interferon Cytokine Res, 32: 341—349.

LI H Y, YAO Y M, SHI Z G, et al, 2003. The potential role of Staphylococcal enterotoxin B in rats with postburn Staphylococcus aureus sepsis ［J］ . Shock, 20: 257—263.

LIN J, YAO Y M, DONG N, et al, 2009. Influence of CD14 polymorphism on CD14 expression in patients with extensive burns ［J］. Burns, 35:365—371.

LIN M T, ALBERTSON T E, 2004. Genomic polymorphisms in sepsis ［J］. Crit Care Med, 32: 569—579.

LIU H, YAO Y M, WANG S B, et al, 2009. Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality ［J］. J Trauma, 66: 859—865.

LUAN Y Y, YAO Y M, SHENG Z Y, et al, 2012. Update on the immunological pathway of negative regulation in acute insults and sepsis ［J］. J Interferon Cytokine Res, 32: 288—298.

RUSSELL J A, 2006. Management of sepsis ［J］. N Engl J Med, 355: 1699—1713.

TERRAGNI P P, ROSBOCH G, TEALDI A, et al, 2007. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome ［J］. Am J Respir Crit Care Med, 175: 160—166.

WIENER R S, WIENER D C, LARSON R J, et al, 2008. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis ［J］ . JAMA, 300: 933—944.

YAO Y M, SHENG Z Y, HUANG L F, et al, 2009. The effect of a novel cytokine, high mobility group box-1 protein, on the development of traumatic sepsis ［J］. Chin J Integr Med, 15: 13—15.

ZHANG L T, YAO Y M, LU J Q, et al, 2008. Recombinant bactericidal/permeability- increasing protein inhibits endotoxin-induced high mobility group box 1 protein gene expression in sepsis ［J］. Shock, 29: 278—284.

ZHANG Q H, YAO Y M, SHENG Z Y, et al, 2009. Dysfunction of neuroendocrine system in sepsis and implication of hormone therapy ［J］. J Geriatr Cardiol, 6: 249—254.

ZHU X M, YAO F H, YAO Y M, et al, 2012. Endoplasmic reticulum stress and its regulator XBP-1 contributes to dendritic cell maturation and activation induced by high mobility group box-1 protein ［J］. Int J Biochem Cell Biol, 44: 1097—1105.